butyric acid has been researched along with Cancer of Ovary in 15 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (20.00) | 18.7374 |
1990's | 10 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (13.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Seifrtová, M | 1 |
Havelek, R | 2 |
Cahlíková, L | 1 |
Hulcová, D | 1 |
Mazánková, N | 1 |
Řezáčová, M | 2 |
Mrkvicova, A | 1 |
Chmelarova, M | 1 |
Peterova, E | 1 |
Baranova, I | 1 |
Kazimirova, P | 1 |
Rudolf, E | 1 |
Krupitza, G | 2 |
Harant, H | 2 |
Dittrich, E | 1 |
Szekeres, T | 2 |
Huber, H | 2 |
Dittrich, C | 2 |
Zoref-Shani, E | 1 |
Lavie, R | 1 |
Bromberg, Y | 1 |
Beery, E | 2 |
Sidi, Y | 1 |
Sperling, O | 1 |
Nordenberg, J | 2 |
Yabushita, H | 2 |
Sartorelli, AC | 1 |
Grill, S | 1 |
Hulla, W | 1 |
Götzinger, N | 1 |
Sauter, M | 1 |
Roemer, K | 1 |
Mueller-Lantzsch, N | 1 |
Noguchi, M | 1 |
Nakanishi, M | 1 |
Suzuki, M | 1 |
Ma, J | 1 |
Usui, N | 1 |
Furugen, Y | 1 |
Takada, M | 1 |
Hay, FG | 2 |
Duncan, LW | 1 |
Langdon, SP | 2 |
Leonard, RC | 2 |
Nakai, T | 1 |
Endo, K | 1 |
Hosono, M | 1 |
Saga, T | 1 |
Watanabe, Y | 1 |
Sakahara, H | 1 |
Imai, K | 1 |
Yachi, A | 1 |
Kiyozuka, Y | 1 |
Ishiwata, I | 1 |
Brooks, SE | 1 |
Timmerman, J | 1 |
Lau, CC | 1 |
Tsao, SW | 1 |
Knapp, RC | 1 |
Sheets, EE | 1 |
Wasserman, L | 1 |
Aviram, R | 1 |
Levavi, H | 1 |
Ovadia, J | 1 |
Novogrodsky, A | 1 |
Chang, CC | 1 |
Chao, KC | 1 |
Ng, HT | 1 |
Hawkes, MM | 1 |
Lawrie, SS | 1 |
Schol, DJ | 1 |
Hilgers, J | 1 |
Smyth, JF | 1 |
15 other studies available for butyric acid and Cancer of Ovary
Article | Year |
---|---|
Haemanthamine alters sodium butyrate-induced histone acetylation, p21
Topics: Acetylation; Amaryllidaceae Alkaloids; Butyric Acid; Cell Cycle; Cell Division; Cell Line, Tumor; Ch | 2017 |
The effect of sodium butyrate and cisplatin on expression of EMT markers.
Topics: Antigens, CD; Antineoplastic Agents; Butyric Acid; Cadherins; Cell Cycle; Cell Line, Tumor; Cell Pro | 2019 |
Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian carcinoma cells.
Topics: Adenocarcinoma; Base Sequence; Blotting, Northern; Butyrates; Butyric Acid; Cell Line; Cell Nucleus; | 1995 |
Effects of differentiation-inducing agents on purine nucleotide metabolism in an ovarian cancer cell line.
Topics: Butyrates; Butyric Acid; Cell Differentiation; Cell Division; Dimethyl Sulfoxide; Female; Guanosine | 1994 |
Effects of sodium butyrate, dimethylsulfoxide and dibutyryl cAMP on the poorly differentiated ovarian adenocarcinoma cell line AMOC-2.
Topics: Adenocarcinoma; Alkaline Phosphatase; Bucladesine; Butyrates; Butyric Acid; Cell Differentiation; Cy | 1993 |
Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells.
Topics: Adenylyl Cyclases; Butyrates; Butyric Acid; Cell Division; Cell Line; Colforsin; Cyclic AMP-Dependen | 1996 |
Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours.
Topics: Azacitidine; Butyrates; Butyric Acid; DNA Methylation; DNA, Viral; Female; Gene Products, gag; Human | 1996 |
Emergence of an irreversible differentiated subclone from the poorly differentiated ovarian adenocarcinoma cell line AMOC-2 treated with sodium butyrate.
Topics: Adenocarcinoma; Animals; Blotting, Western; Butyrates; Butyric Acid; Cell Count; Cell Differentiatio | 1997 |
[Production of CA125 in cell lines derived from human ovarian carcinoma: in relation to the cell cycle].
Topics: Antigens, Tumor-Associated, Carbohydrate; Butyrates; Butyric Acid; Cell Cycle; Cystadenocarcinoma; E | 1992 |
Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrate.
Topics: Adenocarcinoma; Alkaline Phosphatase; Antibodies, Monoclonal; Antigens, Neoplasm; Butyrates; Butyric | 1991 |
Drug effects on CA125 antigen expression and antibody binding to cancer cells.
Topics: Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Binding Sites, Antibody; Bucladesi | 1991 |
Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433).
Topics: Adenocarcinoma; Alkaline Phosphatase; Antigens, Tumor-Associated, Carbohydrate; Bucladesine; Butyrat | 1991 |
Sodium butyrate enhances the activities of membranal enzymes and increases drug sensitivity in a cell line from ascitic fluid of an ovarian carcinoma patient.
Topics: Alkaline Phosphatase; Ascitic Fluid; Butyrates; Butyric Acid; Cell Line; Cell Membrane; Cisplatin; D | 1989 |
Effects of sodium butyrate on the secretion of beta-2-microglobulin and calcitonin in a human ovarian cancer cell line OC-3-VGH.
Topics: Adenocarcinoma; beta 2-Microglobulin; Butyrates; Butyric Acid; Calcitonin; Cell Division; Cell Line; | 1988 |
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines.
Topics: Adenocarcinoma; Alkaline Phosphatase; Antigens, Neoplasm; Butyrates; Butyric Acid; Cell Differentiat | 1988 |